7 min. Read

PHTI’s premature PDT pricing analysis. CPT billing code rejects.

Issue 247

Welcome back to E&O: SaMD, a paying subscribers-only weekly newsletter focused on the world of digital pharma products, prescription digital therapeutics and other FDA-regulated digital health.

E&O: Software as a Medical Device

Here's two quick notes before we get into new CPT billing code application rejections and the latest PHTI assessment, which used some curious numbers to conclude that mental health-focused PDTs should be

Subscribers Only

It's a good one, too.

This digital health research is for Exits & Outcomes subscribers only. Subscribe now to get the weekly newsletter. Enter your email below to subscribe today!

Newsletters

ACCESS Model’s shockingly low payments. DMHT Rx count.

2.13.26

7 min. Read

HLTH acquisition price. Estimating Pomelo Care pricing, revenue, and more

1.09.26

7 min. Read

CMS to pay for ADHD DTx. More PFS notes. Two FDA De Novos.

11.07.25

6 min. Read

Pricing for Sword Health, Hinge Health, Joint Academy in the UK.

10.31.25

7 min. Read

Spring, Slingshot AI, Click and others write FDA about GenAI. Big Health board departs.

10.24.25

7 min. Read

Cigna clarifies new non-coverage policy for PDTs. Bevel $10M. FDA GenAI comments.

10.17.25

5 min. Read

Revisiting E&O scoops, pricing intel, revenue finds

10.10.25

7 min. Read

Big Health’s 2024 revenue shrinks. 2025: Runway worries.

9.26.25

5 min. Read

Kavira Health pricing. What did Swing Therapeutics buy? PFS Comments.

9.18.25

7 min. Read

Cerebral’s $25M M&A. Amazon-Fay. Oshi growth numbers.

9.12.25

4 min. Read

PHTI’s premature PDT pricing analysis. CPT billing code rejects.

E&O: Software as a Medical Device

Subscribers Only

E&O's weekly newsletter.